ZA201600894B - Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes - Google Patents
Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetesInfo
- Publication number
- ZA201600894B ZA201600894B ZA2016/00894A ZA201600894A ZA201600894B ZA 201600894 B ZA201600894 B ZA 201600894B ZA 2016/00894 A ZA2016/00894 A ZA 2016/00894A ZA 201600894 A ZA201600894 A ZA 201600894A ZA 201600894 B ZA201600894 B ZA 201600894B
- Authority
- ZA
- South Africa
- Prior art keywords
- dimethylpropan
- aminium
- diabetes
- carboxy
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13186201 | 2013-09-26 | ||
| PCT/IB2014/064514 WO2015044828A1 (en) | 2013-09-26 | 2014-09-15 | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201600894B true ZA201600894B (en) | 2017-05-31 |
Family
ID=49231372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2016/00894A ZA201600894B (en) | 2013-09-26 | 2016-02-09 | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes |
Country Status (9)
| Country | Link |
|---|---|
| CN (1) | CN105530929B (en) |
| AR (1) | AR099638A1 (en) |
| BR (1) | BR112016004211B1 (en) |
| CA (1) | CA2924682C (en) |
| JO (1) | JO3333B1 (en) |
| MX (1) | MX368505B (en) |
| TN (1) | TN2016000064A1 (en) |
| WO (1) | WO2015044828A1 (en) |
| ZA (1) | ZA201600894B (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2067474A1 (en) * | 2007-12-05 | 2009-06-10 | Grindeks, a joint stock company | Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate |
| LV14345B (en) * | 2009-10-22 | 2011-07-20 | Grindeks, A/S | 4-[ethyl(dimethyl)ammonio]butanoate and their use in the treatment of cardiovascular diseases |
| US20140088125A1 (en) | 2011-04-27 | 2014-03-27 | Jsc Grindeks | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease |
-
2014
- 2014-08-05 JO JOP/2014/0244A patent/JO3333B1/en active
- 2014-08-13 AR ARP140103039A patent/AR099638A1/en unknown
- 2014-09-15 CA CA2924682A patent/CA2924682C/en active Active
- 2014-09-15 TN TN2016000064A patent/TN2016000064A1/en unknown
- 2014-09-15 CN CN201480050485.3A patent/CN105530929B/en active Active
- 2014-09-15 BR BR112016004211-5A patent/BR112016004211B1/en active IP Right Grant
- 2014-09-15 MX MX2016003347A patent/MX368505B/en active IP Right Grant
- 2014-09-15 WO PCT/IB2014/064514 patent/WO2015044828A1/en active Application Filing
-
2016
- 2016-02-09 ZA ZA2016/00894A patent/ZA201600894B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN105530929B (en) | 2018-03-02 |
| TN2016000064A1 (en) | 2017-07-05 |
| BR112016004211A2 (en) | 2017-08-01 |
| CA2924682C (en) | 2018-02-27 |
| MX368505B (en) | 2019-10-04 |
| MX2016003347A (en) | 2016-06-24 |
| CN105530929A (en) | 2016-04-27 |
| BR112016004211B1 (en) | 2022-09-06 |
| JO3333B1 (en) | 2019-03-13 |
| WO2015044828A1 (en) | 2015-04-02 |
| AR099638A1 (en) | 2016-08-10 |
| CA2924682A1 (en) | 2015-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1216251A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| EP2964022A4 (en) | Pain medicine combination and uses thereof | |
| IL254142B (en) | Tradipitant for use in the treatment of a tradipitant-responsive disease or condition | |
| PL3004112T3 (en) | Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease | |
| HK1212688A1 (en) | Pyridone derivatives and their use in the treatment, amelioration or prevention of a viral disease | |
| ZA201607581B (en) | Dosage forms and therapeutic uses l-4lchlorokynurenine | |
| LT3057589T (en) | (s)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| HK1211288A1 (en) | Naphthyridinone derivatives and their use in the treatment,amelioration or prevention of a viral disease | |
| IL244693A0 (en) | Piperazine derivatives and the use thereof as medicament | |
| ZA201508050B (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias | |
| EP3065548A4 (en) | Fibrosis inhibiting compounds and methods of use thereof in the prevention or treatment of fibrosing diseases | |
| GB2510477B (en) | Formulations for use in the treatment of chronic fatigue and associated conditions, etc | |
| RS55061B1 (en) | Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome | |
| ZA201600894B (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes | |
| AP2015008726A0 (en) | Low-glycerin-formulations for hiv treatment and prevention | |
| ZA201505093B (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the treatment of atherosclerosis | |
| AP2015008849A0 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| GB201312131D0 (en) | Drug combination and its use in therapy | |
| GB201312129D0 (en) | Drug combination and its use in therapy | |
| GB201312128D0 (en) | Drug combination and its use in therapy |